Unicycive TherapeuticsUNCY
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 35 institutions reported holding Unicycive Therapeutics Inc. (UNCY) in their 13F filings, up 5 from Q3 2025. 7 opened new positions and 2 sold out. The largest holders were Vivo Capital, LLC ($10.3M), Millennium Management ($5.9M) and Octagon Capital Advisors LP ($5.8M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Unicycive Therapeutics Inc.
- CUSIP
- 90466Y202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $8.4M |
| Exits | 2 | $198K |
All 13F filers, Q3 2025 → Q4 2025: 2,004,079 shares bought and 121,436 shares sold, net +1,882,643 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Vivo Capital, LLC | 0.67% | No change | 1,789,916 | $10.3M |
| Millennium Management | 0.00% | New | 1,014,843 | $5.9M |
| Octagon Capital Advisors LP | 0.72% | No change | 1,000,000 | $5.8M |
| Nantahala Capital Management, LLC | 0.32% | No change | 939,202 | $5.4M |
| Great Point Partners LLC | 1.49% | No change | 796,558 | $4.6M |
| Vanguard Group Inc. | 0.00% | Add +19.7% | 788,587 | $4.6M |
| Logos Global Management LP | 0.18% | No change | 473,563 | $2.7M |
| Citadel Advisors | 0.00% | Add +519.8% | 258,301 | $1.5M |
| Cantor Fitzgerald, L. P. | 0.03% | New | 200,000 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Add +36.2% | 171,290 | $989K |
| BNP Paribas Financial Markets | 0.00% | Add +181249.1% | 99,742 | $576K |
| Pavaki Capital Management LLC | 0.36% | — | 90,000 | $519K |
| Dauntless Investment Group, LLC | 1.90% | New | 89,415 | $516K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 78,200 | $451K |
| State Street Corp. | 0.00% | Add +19.0% | 65,227 | $376K |
| Acuta Capital Partners, LLC | 0.23% | No change | 59,985 | $346K |
| Squarepoint Ops LLC | 0.00% | Reduce -52.9% | 55,305 | $319K |
| Morgan Stanley | 0.00% | Add +339.0% | 46,584 | $269K |
| Quadrature Capital Ltd | 0.00% | New | 39,114 | $226K |
| BlackRock, Inc. | 0.00% | No change | 36,355 | $210K |
| Northern Trust Corp. | 0.00% | Add +9.9% | 35,937 | $207K |
| XTX Topco Ltd | 0.01% | Reduce -6.4% | 35,405 | $204K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -16.9% | 22,413 | $155K |
| Susquehanna International Group, LLP | 0.00% | New | 24,931 | $144K |
| UBS Group AG | 0.00% | Add +265.6% | 19,905 | $115K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,920 | $11K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.4% | 558 | $3K |
| Rockefeller Capital Management L.P. | 0.00% | No change | 500 | $3K |
| TFC Financial Management, Inc. | 0.00% | No change | 300 | $2K |
| Citigroup Inc. | 0.00% | Reduce -96.6% | 228 | $1K |
| Bank of America Corp. | 0.00% | Reduce -81.6% | 152 | $877 |
| Harbour Investments, Inc. | 0.00% | No change | 100 | $577 |
| Barclays PLC | 0.00% | No change | 80 | $462 |
| Bogart Wealth, LLC | 0.00% | No change | 6 | $35 |
| Danske Bank A/S | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is UNCY's weight in each manager's 13F, not the share of Unicycive Therapeutics Inc. the manager owns.